Acadian Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-557
| Closed | -$40K | – | 1875 |
|
|
2024
Q1 | $40K | Sell |
557
-3,588
| -87% | -$240K | ﹤0.01% | 1406 |
|
|
2023
Q4 | $252K | Sell |
4,145
-46,032
| -92% | -$2.73M | ﹤0.01% | 1190 |
|
|
2023
Q3 | $2.86M | Buy |
50,177
+17,019
| +51% | +$1.03M | 0.01% | 593 |
|
|
2023
Q2 | $1.97M | Sell |
33,158
-6,772
| -17% | -$405K | 0.01% | 695 |
|
|
2023
Q1 | $2.5M | Sell |
39,930
-210,386
| -84% | -$13.1M | 0.01% | 646 |
|
|
2022
Q4 | $15.7M | Sell |
250,316
-200,786
| -45% | -$11.5M | 0.08% | 215 |
|
|
2022
Q3 | $22.5M | Sell |
451,102
-64,395
| -12% | -$3.57M | 0.12% | 165 |
|
|
2022
Q2 | $30.3M | Sell |
515,497
-54,672
| -10% | -$3.01M | 0.16% | 148 |
|
|
2022
Q1 | $30.2M | Buy |
570,169
+69,954
| +14% | +$4.04M | 0.12% | 175 |
|
|
2021
Q4 | $30.3M | Sell |
500,215
-135,133
| -21% | -$8.02M | 0.11% | 169 |
|
|
2021
Q3 | $35.6M | Sell |
635,348
-124,130
| -16% | -$6.82M | 0.14% | 143 |
|
|
2021
Q2 | $39.6M | Sell |
759,478
-224,576
| -23% | -$10.8M | 0.15% | 146 |
|
|
2021
Q1 | $43.4M | Sell |
984,054
-240,679
| -20% | -$10.1M | 0.17% | 130 |
|
|
2020
Q4 | $42.7M | Sell |
1,224,733
-162,344
| -12% | -$5.76M | 0.17% | 122 |
|
|
2020
Q3 | $50.5M | Sell |
1,387,077
-38,371
| -3% | -$1.43M | 0.21% | 105 |
|
|
2020
Q2 | $53.5M | Sell |
1,425,448
-77,334
| -5% | -$3.09M | 0.23% | 107 |
|
|
2020
Q1 | $55.1M | Buy |
1,502,782
+71,201
| +5% | +$2.77M | 0.32% | 81 |
|
|
2019
Q4 | $58M | Sell |
1,431,581
-100,366
| -7% | -$3.74M | 0.26% | 94 |
|
|
2019
Q3 | $53.1M | Buy |
1,531,947
+48,322
| +3% | +$1.59M | 0.23% | 108 |
|
|
2019
Q2 | $47M | Buy |
1,483,625
+102,314
| +7% | +$3.04M | 0.23% | 109 |
|
|
2019
Q1 | $41.3M | Buy |
1,381,311
+145,809
| +12% | +$4.18M | 0.18% | 125 |
|
|
2018
Q4 | $38.2M | Buy |
1,235,502
+233,793
| +23% | +$8.53M | 0.19% | 123 |
|
|
2018
Q3 | $38M | Buy |
1,001,709
+252,358
| +34% | +$9.54M | 0.16% | 139 |
|
|
2018
Q2 | $28.8M | Buy |
749,351
+52,198
| +7% | +$1.76M | 0.12% | 154 |
|
|
2018
Q1 | $23.5M | Buy |
697,153
+162,431
| +30% | +$6.23M | 0.1% | 172 |
|
|
2017
Q4 | $23.7M | Buy |
534,722
+264,057
| +98% | +$12M | 0.1% | 174 |
|
|
2017
Q3 | $13.6M | Sell |
270,665
-50,823
| -16% | -$2.6M | 0.06% | 244 |
|
|
2017
Q2 | $17M | Sell |
321,488
-232,589
| -42% | -$12.5M | 0.08% | 218 |
|
|
2017
Q1 | $30.8M | Buy |
554,077
+455,704
| +463% | +$25.1M | 0.14% | 151 |
|
|
2016
Q4 | $5.12M | Sell |
98,373
-21,713
| -18% | -$1.05M | 0.02% | 409 |
|
|
2016
Q3 | $5.8M | Sell |
120,086
-1,027,949
| -90% | -$52M | 0.03% | 349 |
|
|
2016
Q2 | $63.6M | Sell |
1,148,035
-396,728
| -26% | -$21.9M | 0.33% | 91 |
|
|
2016
Q1 | $82.5M | Buy |
1,544,763
+1,106,216
| +252% | +$54.5M | 0.42% | 73 |
|
|
2015
Q4 | $22.6M | Buy |
438,547
+438,271
| +158,794% | +$21.8M | 0.12% | 189 |
|
|
2015
Q3 | $12K | Sell |
276
-2,365
| -90% | -$112K | ﹤0.01% | 1101 |
|
|
2015
Q2 | $122K | Sell |
2,641
-188,770
| -99% | -$8.26M | ﹤0.01% | 988 |
|
|
2015
Q1 | $8.21M | Sell |
191,411
-582,808
| -75% | -$22.2M | 0.04% | 314 |
|
|
2014
Q4 | $26.9M | Sell |
774,219
-259,958
| -25% | -$8.63M | 0.12% | 176 |
|
|
2014
Q3 | $33.5M | Buy |
1,034,177
+266,767
| +35% | +$8.92M | 0.16% | 159 |
|
|
2014
Q2 | $26M | Buy |
+767,410
| New | +$24.6M | 0.13% | 178 |
|
Other funds holding PBH
AI
Acadian Asset Management's PBH Position: Q2 2024 in Review
Acadian Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 557 shares — an estimated $40K sold.
Acadian Asset Management first reported a position in PBH in Q2 2014 and held it in 40 quarters. The position peaked at $82.5M in Q1 2016. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.
- Acadian Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
- Acadian Asset Management sold 557 Prestige Consumer Healthcare shares in Q2 2024, an estimated $40K.
- Acadian Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2014 and held it in 40 quarters.
- Acadian Asset Management's Prestige Consumer Healthcare position peaked at $82.5M in Q1 2016.
- 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.
Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.